Peptide therapy, decoded.
200+ clinical monographs, interactive dosing calculators, and community reviews — all PubMed-referenced and free to access.
Latest Research & Education
Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of Coagulation Factor Xa-PAR-1 Signaling Axis
Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, demonstrated significant antifibrotic activity in pulmonary fibrosis models by functioning as a PAR-1 antagonist that disrupts the coagulation factor Xa-PAR-1 signaling axis. The peptide inhibited fibroblast invasion and migration with a favorable safety profile—no adverse effects at 0.5 mg/kg/day and only mild hepatomegaly at supratherapeutic doses.
Guide complet de la thérapie peptidique 2026
La thérapie peptidique en 2026 : mécanismes d'action, peptides approuvés par l'EMA et l'ANSM, applications cliniques validées, cadre réglementaire francophone et perspectives. Un guide complet pour comprendre cette classe thérapeutique en pleine expansion.
Antimicrobial Peptides Show Promise as Cancer Therapeutics: A 2026 Systematic Review
A new review in Frontiers in Medicine evaluates antimicrobial peptides (AMPs) as anticancer agents, finding selective cytotoxicity against tumor cells via membrane disruption and apoptosis induction, though clinical evidence remains limited to early-phase trials.
Pemvidutide Achieves MASH Resolution in Phase 2b IMPACT Trial
The Lancet published Phase 2b results for pemvidutide, a dual GLP-1/glucagon agonist, showing significant MASH resolution without worsening fibrosis at 24 weeks. FDA granted Breakthrough Therapy designation in January 2026.
Retatrutide Achieves 28.7% Weight Loss in TRIUMPH-4 Phase 3 Trial
Eli Lilly's triple GIP/GLP-1/glucagon agonist retatrutide achieved an average 28.7% body weight reduction at 68 weeks in the pivotal TRIUMPH-4 trial — the largest weight loss ever reported for any anti-obesity medication in Phase 3.
Les peptides sont-ils sûrs ? Ce que montre la recherche clinique
Les peptides thérapeutiques suscitent un intérêt croissant, mais sont-ils réellement sûrs ? Cet article passe en revue les données cliniques, les cadres réglementaires (ANSM, EMA, Swissmedic) et les profils de tolérance pour vous aider à comprendre ce que la science dit vraiment sur la sécurité des peptides.
Clinical Calculators & Tools
Calculateur de Reconstitution
Calculez les unités de seringue et le dosage à partir de peptides lyophilisés
Try it →⚖️Calculateur de Posologie par Poids Corporel
Calculez la dose en fonction du poids du patient et des protocoles mcg/kg
Try it →⏱️Calculateur de Demi-vie et d'Intervalle de Posologie
Estimez l'état d'équilibre, les intervalles de posologie et les fenêtres d'élimination
Try it →🔄Convertisseur d'Unités de Peptide
Convertissez entre microgrammes, milligrammes, UI et unités de seringue
Try it →Real Experiences from Real UsersNEW
Game-changer for my knee recovery
After 6 weeks of subcutaneous injections, the chronic tendon pain I'd had for 2 years was down to almost nothing. Combined with PT, the results were remarkable.
Verified user · 8 weeks
Steady weight loss, minimal sides
Lost 14 lbs over 3 months on the titration schedule. Nausea was real the first 2 weeks but manageable. Worth it for the appetite control alone.
Verified user · 12 weeks
Best GH stack I've tried
Noticeably better sleep by week 2, improved recovery from training by week 4. Skin quality improved. No water retention like with GHRP-6.
Verified user · 16 weeks
Monographs
Interactive Tools
Languages
Independent
Restez en Avance
Mises à jour cliniques, actualités du secteur, nouvelles synthèses de recherche et lancements d'outils.
Nous respectons votre vie privée. Désabonnez-vous à tout moment.